Medacta announced successful completion in Australia using the first surgery with its NextAR™ TKA system, following recent approval from the region's Therapeutic Goods Administration.
NextAR, an augmented reality-based platform, is designed to improve efficiency, precision and personalization in total knee replacement. It comprises augmented reality glasses and an infrared single-use tracking system, provided with a low upfront capital investment by clinics and hospitals.
The NextAR system received FDA 510(k) clearance earlier this year.
Francesco Siccardi, CEO of Medacta, said, "The feedback we are receiving is very positive and I am confident that it will be a game-changer in the years to come. We look forward to extending this technology to spine, shoulder, and hip procedures, with the goal of improving the experience of orthopaedic surgeons and their patients with a very competitive and sustainable healthcare solution."